Table 2 Crude and Adjusted Parameter Estimates of Candidate and Final Adjusted Model Covariates, Respectively.
Crude Models | Final Adjusted Model | |||||
|---|---|---|---|---|---|---|
Model Parameters | β (SE) | Prevalence Ratio (PR) | P-value | β (SE) | Prevalence Ratio (PR) | P-value |
QIC^ | 15022.4075 | |||||
Intercept | – | – | – | −1.5645 (0.0784) | – | <0.0001 |
Candidate Covariates+ | ||||||
Insurance | ||||||
Private | – | REF | – | – | REF | – |
Medicaid | 0.5162 (0.0656) | 1.68 (1.47, 1.91) | <0.0001 | 0.2859 (0.0640) | 1.33 (1.17, 1.51) | <0.0001 |
Medicare | 0.1478 (0.0662) | 1.16 (1.02, 1.32) | 0.0256 | 0.2026 (0.0649) | 1.22 (1.08, 1.39) | 0.0018 |
Other | 0.1413 (0.1141) | 1.15 (0.92, 1.44) | 0.2154 | 0.0369 (0.1075) | 1.04 (0.84, 1.28) | 0.7311 |
Age | -0.0113 (0.0013) | 0.99 (0.99, 0.99) | <0.0001 | -0.0075 (0.0012) | 0.99 (0.99, 0.99) | <0.0001 |
Race/Ethnicity | ||||||
White, NH | – | REF | – | – | REF | – |
American Indian or Alaskan Native, NH | -0.1280 (0.2105) | 0.88 (0.58, 1.33) | 0.5433 | -0.3043 (0.1560) | 0.74 (0.54, 1.00) | 0.0512 |
Asian, NH | -0.0374 (0.1535) | 0.96 (0.74, 1.30) | 0.8076 | 0.0377 (0.1272) | 1.04 (0.81, 1.33) | 0.7667 |
Black, NH | 0.2314 (0.0438) | 1.26 (1.16, 1.357 | <0.0001 | 0.0481 (0.0362) | 1.05 (0.98, 1.13) | 0.1837 |
Hispanic or Latino | 0.2507 (0.0716) | 1.29 (1.12, 1.48) | 0.0005 | 0.1376 (0.0549) | 1.15 (1.03, 1.28) | 0.0121 |
Other Pacific Islander, NH | 0.7514 (0.3791) | 2.12 (1.01, 4.46) | 0.0474 | 0.6067 (0.2322) | 1.83 (1.16, 2.89) | 0.0090 |
Two or more races, NH | 0.3609 (0.1518) | 1.43 (1.07, 1.93) | 0.0175 | 0.1705 (0.1015) | 1.19 (0.97, 1.45) | 0.0931 |
Emergency Room Encounters | 0.0381 (0.0022) | 1.04 (1.03, 1.04) | <0.0001 | 0.0161 (0.0032) | 1.02 (1.01, 1.02) | <0.0001 |
Behavioral Health Inpatient Encounters | 0.2802 (0.0137) | 1.32 (1.29, 1.36) | <0.0001 | 0.0928 (0.0181) | 1.10 (1.06, 1.14) | <0.0001 |
Prior Relapses Episodes | 0.1194 (0.0054) | 1.13 (1.11, 1.14) | <0.0001 | 0.0460 (0.0078) | 1.05 (1.03, 1.06) | <0.0001 |
LAI Prescriptions | 0.0228 (0.0080) | 1.02 (1.01, 1.04) | 0.0045 | 0.0100 (0.0047) | 1.01 (1.00, 1.02) | 0.0349 |
Substance Use Diagnosis | 0.5517 (0.0442) | 1.74 (1.59, 1.89) | <0.0001 | 0.2866 (0.0353) | 1.33 (1.24, 1.43) | <0.0001 |
Extrapyramidal Symptoms | 0.7878 (0.0427) | 2.20 (2.02, 2.39) | <0.0001 | 0.5746 (0.0385) | 1.78 (1.65, 1.92) | <0.0001 |
Outpatient Encounters | 0.0077 (0.0016) | 1.01 (1.00, 1.01) | <0.0001 | – | – | – |
Inpatient Encounters | 0.1768 (0.0260) | 1.19 (1.13, 1.26) | <0.0001 | – | – | – |
Behavioral Health Other Encounters | 0.0200 (0.0034) | 1.02 (1.01, 1.03) | <0.0001 | – | – | – |
Care Escalation Episodes | 0.0462 (0.0030) | 1.05 (1.04, 1.05) | <0.0001 | – | – | – |
Medication Switch Episodes | 0.3016 (0.0162) | 1.35 (1.31, 1.40) | <0.0001 | – | – | – |
Anticholinergic Prescriptions | 0.0222 (0.0022) | 1.02 (1.02, 1.03) | <0.0001 | – | – | – |
Antidepressant Prescriptions | 0.0208 (0.0017) | 1.02 (1.02, 1.02) | <0.0001 | – | – | – |
Anticonvulsant Prescriptions | 0.0137 (0.0014) | 1.01 (1.01, 1.02) | <0.0001 | – | – | – |
Anxiolytic Prescriptions | 0.0222 (0.0017) | 1.02 (1.02, 1.03) | <0.0001 | – | – | – |
Mood Stabilizer Prescriptions | 0.0236 (0.0034) | 1.02 (1.02, 1.03) | <0.0001 | – | – | – |
Atypical Antipsychotic Prescriptions | 0.0193 (0.0013) | 1.02 (1.02, 1.02) | <0.0001 | – | – | – |
Typical Antipsychotic Prescriptions | 0.0306 (0.0027) | 1.03 (1.03, 1.04) | <0.0001 | – | – | – |
Obesity Diagnosis | -0.2054 (0.0645) | 0.81 (0.71, 0.92) | 0.0014 | – | – | – |
Lipid Disorder Diagnosis | -0.2199 (0.0457) | 0.80 (0.73, 0.88) | <0.0001 | – | – | – |
Hypertension Diagnosis | -0.1878 (0.0475) | 0.83 (0.76, 0.91) | <0.0001 | – | – | – |
Diabetes Diagnosis | -0.1244 (0.0532) | 0.88 (0.80, 0.98) | 0.0194 | – | – | – |
Sex | ||||||
Female | – | REF | – | – | – | – |
Male | 0.0130 (0.0404) | 1.01 (0.94, 1.10) | 0.7483 | – | – | – |
